Wilson Sonsini Goodrich & Rosati represented Celest Therapeutics in the transaction. Celest Therapeutics (Shanghai) Co. Ltd (“Celest”) announced a collaboration with Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here